1.0The Medical Xchangehttps://themedicalxchange.com/en/Sensitive Tool Identified for Early Detection of Alzheimer's Disease - The Medical Xchangerich600338<blockquote class="wp-embedded-content" data-secret="bBkmeCSWS6"><a href="https://themedicalxchange.com/en/2013/08/01/alzheimers-association-international-conference-aa/">Sensitive Tool Identified for Early Detection of Alzheimer’s Disease</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://themedicalxchange.com/en/2013/08/01/alzheimers-association-international-conference-aa/embed/#?secret=bBkmeCSWS6" width="600" height="338" title="“Sensitive Tool Identified for Early Detection of Alzheimer’s Disease” — The Medical Xchange" data-secret="bBkmeCSWS6" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://themedicalxchange.com/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
https://themedicalxchange.com/wp-content/uploads/2013/08/2340_AAIC_Table_1_EN.PNG960720Boston – More sensitive methods for early detection of Alzheimer's disease (AD) that reduce or circumvent the major weaknesses of previous tools are expected to be a major boost in the objective assessment of suspected memory loss. While several approaches are being pursued, most can be administered repeatedly by healthcare staff with minimal training. Of the tests, the advantage of the one that appears closest to clinical application is its relative freedom from confounders such as baseline intelligence. Cognitive function and education have been important obstacles to the reliability of earlier assessments. Tests of early memory loss are expected to allow clinicians to provide reliable information to patients and families even when symptoms are discrete.